Substance / Medication

Botulinum toxin type B

Overview

Active Ingredient
botulinum toxin type B
RxNorm CUI
2167673

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Botulinum toxin type B for cervical dystonia.
Marques Raquel E, Duarte Gonçalo S, Rodrigues Filipe B et al. · Cochrane Database Syst Rev · 2016
PMID: 27176573Meta-AnalysisFull text (PMC)
Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
Duarte Gonçalo S, Castelão Mafalda, Rodrigues Filipe B et al. · Cochrane Database Syst Rev · 2016
PMID: 27782297Meta-AnalysisFull text (PMC)
Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
Costa J, Borges A, Espírito-Santo C et al. · Cochrane Database Syst Rev · 2005
PMID: 15674940Meta-Analysis
Botulinum toxin type B for cervical dystonia.
Costa J, Espírito-Santo C, Borges A et al. · Cochrane Database Syst Rev · 2005
PMID: 15674941Meta-Analysis
Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study.
Grimstad Øystein, Kvammen Bjørn Øivind, Swartling Carl · Am J Clin Dermatol · 2020
PMID: 32761500RCTFull text (PMC)
Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study.
Gracies Jean-Michel, Bayle Nicolas, Goldberg Sarah et al. · Arch Phys Med Rehabil · 2014
PMID: 24709034RCT
A split-face study using botulinum toxin type B to decrease facial erythema index.
Oh Yu-Jin, Lee Na-Young, Suh Dong-Hye et al. · J Cosmet Laser Ther · 2011
PMID: 21848448RCT
Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients.
Jackson Carlayne E, Gronseth Gary, Rosenfeld Jeffrey et al. · Muscle Nerve · 2009
PMID: 19145653RCT
Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling.
Lagalla Giovanni, Millevolte Marzia, Capecci Marianna et al. · J Neurol · 2009
PMID: 19401804RCT
Comparative electrophysiological study of response to botulinum toxin type B in Japanese and Caucasians.
Arimura Kimiyoshi, Arimura Yumiko, Takata Yoshiharu et al. · Mov Disord · 2008
PMID: 17999429RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Botulinum toxin type B (substance)
SNOMED CT
129471005
UMLS CUI
C0006051
RxNorm CUI
2167673

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.